[The validation and effect of the prophylactic (antirelapse) treatment of peptic ulcer patients with chlorozil and metronidazole].
Tsimmerman
Ia S
IaS
Kiseleva
R P
RP
Freĭnd
G G
GG
D000328:Adult; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002794:Choline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use*; D008875:Middle Aged; D009784:Occupational Diseases / Q000188:drug therapy / Q000517:prevention & control; D011890:Railroads; D012008:Recurrence; D012800:Siberia; D013276:Stomach Ulcer / Q000188:drug therapy* / Q000517:prevention & control
D000897:Anti-Ulcer Agents; D008795:Metronidazole; C053909:chlorozil; D002794:Choline
Obosnovanie i éffekt profilakticheskogo (protivoretsidivnogo) lecheniia bol'nykh iazvennoĭ bolezn'iu khlorozilom i metronidazolom.